Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company operates across several major therapeutic areas, including Oncology, Rare Diseases, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. AstraZeneca is well-known for its extensive portfolio of blockbuster drugs such as Tagrisso, Imfinzi, Farxiga, and Lynparza. While the company has a historical presence in Neuroscience with products like Seroquel, it has shifted its primary focus toward high-growth areas like oncology and biologics. AstraZeneca maintains a robust global manufacturing and R&D footprint, positioning itself as a leader in precision medicine and innovative therapeutic modalities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AZ for trazodone.